细胞图谱识别肺纤维化早期促纤维化肺泡2型细胞特征
研究利用SPC-creTRF1flox/flox小鼠在肺泡2型细胞中条件性敲除TRF1建立端粒功能障碍模型,通过单细胞RNA测序发现一类富集DNA损伤、衰老、氧化应激和促纤维化基因的病理型AT2细胞,其早期和晚期均有显著p53特征;敲除p53可改善小鼠生存并阻止肺纤维化,p53缺失或抑制还能改善小鼠及IPF肺来源AT2细胞的类器官形成和表面活性蛋白C表达、降低促纤维化基因表达,提示逆转该重编程是IPF潜在治疗策略。
要点
- AT2细胞端粒功能障碍可诱导病理型AT2细胞,富集DNA损伤、衰老及促纤维化特征。
- p53活性增强介导AT2细胞早期转分化和衰老,推动上皮重塑与纤维化。
- 敲除或抑制p53可改善小鼠生存、阻止肺纤维化并改善IPF肺AT2细胞类器官形成。
核心结论
- AT2细胞端粒功能障碍引发的DNA损伤应答通过增强p53活性介导早期AT2细胞转分化与衰老,导致上皮重塑和纤维化。
- 逆转该重编程是管理IPF的潜在治疗途径。
研究设计与样本
- 在SPC-creTRF1flox/flox小鼠中条件性删除AT2细胞的TRF1以建立端粒功能障碍模型。
- 对小鼠肺上皮细胞进行单细胞RNA测序,并对IPF肺AT2细胞在类器官模型中行单细胞RNA测序分析。
主要发现
- SPC-creTRF1flox/flox小鼠中病理型AT2细胞富集DNA损伤、衰老、氧化应激和促纤维化基因,正常AT2细胞减少、club细胞增多。
- 病理型AT2细胞具有不同的早期和晚期基因特征,两个时间点均有显著p53特征。
- 在SPC-creTRF1flox/flox的AT2细胞中遗传删除p53可改善生存并阻止肺纤维化。
- p53删除或抑制可改善SPC-creTRF1flox/flox小鼠或IPF肺来源AT2细胞的类器官形成和表面活性蛋白C表达,并降低促纤维化基因表达。
临床怎么用
- 关注AT2细胞端粒功能障碍与p53活性作为IPF上皮重塑的早期驱动环节。
- p53通路可能作为逆转AT2细胞促纤维化重编程的潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Idiopathic pulmonary fibrosis (IPF) is a progressive, age-associated lung disease characterized by short telomeres in alveolar type 2 (AT2) cells, epithelial remodeling, and fibrosis. OBJECTIVES: This study investigated how telomere dysfunction in AT2 cells lacking telomere repeat binding factor 1 (TRF1) drives lung remodeling in SPC-creTRF1flox/flox mice and its relevance to IPF. METHODS: A mouse model of telomere dysfunction was used to conditionally delete TRF1 in AT2 cells. SPC-creTRF1flox/flox mouse lung epithelial cells were used to perform single-cell RNA sequencing. AT2 cells from IPF lungs were analyzed by single-cell RNA sequencing in an organoid model. MEASUREMENTS AND MAIN RESULTS: Single-cell RNA sequencing revealed distinct pathologic AT2 cells enriched in DNA damage, senescence, oxidative stress, and profibrotic genes, along with fewer "normal" AT2 cells and increased club cells in SPC-creTRF1flox/flox mice. Pathologic AT2 cells showed different early- and late-stage gene signatures, with a prominent p53 signature at both time points. Genetic deletion of p53 in SPC-creTRF1flox/flox AT2 cells improved survival and prevented lung fibrosis. p53 deletion or inhibition improved organoid formation and surfactant protein C expression, as well as reduced profibrotic gene expression in AT2 cells isolated from SPC-creTRF1flox/flox mice or IPF lungs. CONCLUSIONS: These data suggest that the DNA damage response to AT2 cell telomere dysfunction, driven by enhanced p53 activity, mediates early AT2 cell transdifferentiation and senescence, leading to epithelial cell remodeling and fibrosis, and that reversing this reprogramming is a potential therapeutic approach for managing IPF.
引用
- Naikawadi RP, Bazarov A, Wax Ii M, et al. Cellular profiling identifies an early profibrotic alveolar type 2 cell signature in lung fibrosis. Am J Respir Crit Care Med. 2026. PMID: 41738207. doi:10.1093/ajrccm/aamag044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。